320 related articles for article (PubMed ID: 22884417)
21. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
22. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
23. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
24. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
[TBL] [Abstract][Full Text] [Related]
25. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?
Bower JE; Ganz PA; Irwin MR; Kwan L; Breen EC; Cole SW
J Clin Oncol; 2011 Sep; 29(26):3517-22. PubMed ID: 21825266
[TBL] [Abstract][Full Text] [Related]
26. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.
Phillips KM; Jim HS; Small BJ; Laronga C; Andrykowski MA; Jacobsen PB
Cancer; 2012 Apr; 118(7):1925-32. PubMed ID: 22161750
[TBL] [Abstract][Full Text] [Related]
27. Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls.
Patel SK; Breen EC; Paz IB; Kruper L; Mortimer J; Wong FL; Bhatia S; Irwin MR; Behrendt CE
Brain Behav Immun Health; 2023 Oct; 32():100670. PubMed ID: 37637432
[TBL] [Abstract][Full Text] [Related]
28. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
[TBL] [Abstract][Full Text] [Related]
29. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
30. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
31. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
32. Cognitive performance in survivors of breast cancer and markers of biological aging.
Carroll JE; Van Dyk K; Bower JE; Scuric Z; Petersen L; Schiestl R; Irwin MR; Ganz PA
Cancer; 2019 Jan; 125(2):298-306. PubMed ID: 30474160
[TBL] [Abstract][Full Text] [Related]
33. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
[TBL] [Abstract][Full Text] [Related]
34. Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.
Ganz PA; Petersen L; Castellon SA; Bower JE; Silverman DH; Cole SW; Irwin MR; Belin TR
J Clin Oncol; 2014 Nov; 32(31):3559-67. PubMed ID: 25267747
[TBL] [Abstract][Full Text] [Related]
35. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
Weis J; Poppelreuter M; Bartsch HH
Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
[TBL] [Abstract][Full Text] [Related]
36. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
37. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
[TBL] [Abstract][Full Text] [Related]
38. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
39. Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors.
Perik PJ; Van der Graaf WT; De Vries EG; Boomsma F; Messerschmidt J; Van Veldhuisen DJ; Sleijfer DT; Gietema JA
Acta Oncol; 2006; 45(2):175-83. PubMed ID: 16546863
[TBL] [Abstract][Full Text] [Related]
40. Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting.
Root JC; Andreotti C; Tsu L; Ellmore TM; Ahles TA
J Cancer Surviv; 2016 Jun; 10(3):593-9. PubMed ID: 26658913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
